MabPlex
San Diego, CA, United States mabplexinc.com
From their website, Nov 2026
Work here? Claim this listing
- GMP
About
MabPlex provides CDMO services for biopharmaceuticals, including development and manufacturing of mAbs, recombinant proteins, ADCs, and bispecifics. It serves global partners from its US R&D site and manufacturing site in Yantai, China, with headquarters in Yantai, China.
Services
Regulatory Affairs
Supports regulatory strategy, meetings, IND/IMPD/CTA and BLA/MAA submissions, and dossier preparation in eCTD and non-eCTD formats.
CMC Strategy, Management and Communication
Provides CMC strategy consulting and CMC gap analysis for drug development programs.
Medium Manufacturing
Produces serum-free medium for mammalian cell culture for cell line development and cell culture process development.
Cell Line Development
Develops stable mammalian cell lines for antibody production, including CHO-based platforms.
Cell line development
Upstream Process Development
Offers cell culture screening, feeding strategy optimization, clarification development, tech transfer, and scale-up of bioreactor processes.
Downstream Process Development
Develops purification processes for biologics, including chromatography optimization, viral clearance development, and resin lifetime studies.
Formulation Process Development
Supports formulation optimization, stability studies, freeze-thaw testing, agitation/shaking stability, and lyophilization development.
Antibody Drug Conjugation Process Development
Develops ADC processes from linker/toxin synthesis through process characterization and scale-up.
Analytical Method Development
Develops, optimizes, and validates analytical methods for monoclonal antibodies, recombinant proteins, glycoproteins, and ADCs.
Assays & in vitro testing
Protein Expression
Performs gene synthesis, vector construction, and transient expression for recombinant proteins and related biologics.
Protein production
Antibody Humanization
Designs, constructs, and screens humanized antibodies from mouse-origin monoclonal antibody sequences.
Antibody Fc Engineering
Offers Fc engineering to modulate ADCC, CDC, ADCP, and FcRn binding.
Chemical Synthesis
Designs and synthesizes linker-payloads and related precursors for ADC development.
Antibody Drug Conjugation Screening
Provides ADC conjugation services using lysine-based, cysteine-based, and site-specific conjugation strategies.
ADC Assay and Mechanism Study
Conducts early-stage ADC analysis, potency and binding assays, antigen expression detection, endocytosis assays, serum stability, and animal studies.
Assays & in vitro testing
Cell Banking
Provides MCB, WCB, and EOPCB banking services under GMP regulatory requirements.
Protein Related Drug DS/DP Manufacturing
Manufactures drug substance and drug product for proteins, including cell culture, purification, formulation, fill/finish, and packaging.
CDMO: development & manufacturing
ADC DS/DP Manufacturing
Manufactures ADC drug substance and drug product, including conjugation and fill/finish.
CDMO: development & manufacturing
Product Testing
Performs in-process testing, release testing, and stability studies for drug substance and drug product.
Assays & in vitro testing
- Turnaround
- Transient expression 6-8 weeks · Short time (2 months)
- What to send
- Sequence of the mouse-origin monoclonal antibody · Antibody intermediates · Details about the project and/or challenge
Capabilities
- Assays and studies
- ADCs · Process development · CHO · Antibodies · Analytical development · Bioreactors · Mammalian expression · DAR · Free drug ratio · Concentration · Purity · Identity
10 more
Potency · Antigen-binding activity · Fc-receptor binding activity · Cytotoxicity · Endocytosis · Serum stability · Titer · Protein concentration · Osmolality · Bacterial endotoxin - Scale and capacity
- 0-500 mg proteins · Up to 2000L · 40 tons powder medium per year · 1.4 million liters of liquid medium · Broad range of conjugation scales from 10L to 150L · Multiple production scales at 50L, 200L, 500L, 1000L and 2000L · Milligram to kilogram scale
- Therapeutic areas
- CD20+ non-Hodgkin lymphoma
Instruments and platforms
- Ambr® system
Modalities and species
- Modalities
- Small molecule · Antibody · Bispecific · ADC · Recombinant protein
- Species and models
- CHO-K1 · DG44 · DXB11 · CHO-S · Mouse · Rat · Human tumor cell lines
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: manufacturing facilities
Company
- Type
- CRDMO
- Founded
- 2013
Locations
- Address
- 60 Middle Beijing Road Yantai, China (Shandong), Pilot Free Trade Zone HEADQUARTERS No. 60
- Sites
- Yantai, China · San Diego, United States
- Serves
- globally, worldwide
Public records
- Biocom California CRO directory
- ADC, Bispecific, cGMP, Monoclonal Antibodies, recombinant protein source
Similar labs
Work here? Claim this listing